“Point Of Care Testing (POCT) Devices Market Outlook 2024: Global Opportunity And Demand Analysis, Market Forecast, 2018-2024” presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and deal landscapes.

Top Leading Companies: Bayer, Biosite, bioMerieux, Cholestech, Instrumentation Laboratory, Inverness, International Technidyne Corporation, Meridian, Nova Biomedical, Roche, Quidel.

This report provides a detailed analysis of the Point Of Care Testing (POCT) Devices market with description of market sizing and growth, segmentation of market by products & services and major markets, top market players etc. The report recapitulates the factors that will be responsible for the growth in the market in the forecasted period.

Request a Sample Copy at:

Essential points covered in Global Point Of Care Testing (POCT) Devices Market 2018 Research are:-

  • What will the market size and the growth rate be in 2024?
  • What are the key factors driving the Global Point Of Care Testing (POCT) Devices market?
  • What are the key market trends impacting the growth of the Global Point Of Care Testing (POCT) Devices market?
  • What are the challenges to market growth?
  • Who are the key vendors in the Global Point Of Care Testing (POCT) Devices market?
  • What are the market opportunities and threats faced by the vendors in the Global Point Of Care Testing (POCT) Devices market?
  • What are the key outcomes of the five forces analysis of the Global Point Of Care Testing (POCT) Devices market?

This independent 350 pages report guarantees you will remain better informed than your competition. With over 200 tables and figures examining the Point Of Care Testing (POCT) Devices market, the report gives you a visual, one-stop breakdown of the leading products, submarkets and market leader’s market revenue forecasts as well as analysis to 2024.

Furthermore, the report provides a detailed analysis of the Global Point Of Care Testing (POCT) Devices market with analysis of market size by value and volume. Along with this, an analysis of penetration rate and the average revenue generated per user (ARPU) in the market has also been done.

Market Overview:

The point of care testing (POCT) device in healthcare sector focuses on value rather than test volume and reimbursement issues that minimize tests to the optimal point where outcomes won’t suffer while cost efficiencies are gained. The global point of care testing (POCT) diagnostics market is estimated to reach USD 20 billion by the year 2024. Upcoming technological advancements in smart phones, biosensors, lab-on-a-chip and wearable devices tend to transform the whole spectrum of POCT market. The driving force behind these innovations in healthcare is to provide ease of diagnosis where the patient is seen at home. In future POC can be the part of a paradigm shift from curative medicine to predictive, personalized and preemptive medicine. On the basis of settings and operating the POCT devices there are two categories: Non professional settings (scenes, non-medical facilities, home, etc) performed by non-traditional operators and professionals settings (Clinics, hospitals, lab, etc) performed by traditional operators. In Mexico, POCT devices are utilized in self monitoring, over the counter and emergency departments.

One of the driving factor for the growth of POCT devices market is its increasing penetration in developed countries e.g. In most of the European countries like Spain and the UK, the reimbursement system is the reason for augmented demand for POCT devices. The manufacturers are also focusing towards the advancement in point of care devices in terms of design and functionality.

Market Size and Forecast:

The emerging healthcare industry represents more than USD1.3 trillion and is growing at the rate of 6.8% across the globe. Out of which global medical device market in the year 2016 reached USD315 billion on the back of rapid advancement in medical devices technology. However, winning market share in the traditional markets (Western Europe, and the US) will remain difficult due to growing regulatory scrutiny and pricing pressures. German POCT devices market is almost USD 1.2 billion. In 2013, North America (US, Canada and Mexico) held the largest share of the global POC diagnostics market because of huge and increasing addressable patient population base. The US will remain the largest producer and consumer of medical devices, accounting for 26% of the global market. Similarly, the demand growth for medical devices in Western Europe is expected to stagnate, constrained by the declining expenditure from the budget-constrained healthcare industry. Asia Pacific, however, presents unique opportunities for medical device producers. For instance, China’s and India’s healthcare service revenues are advanced by 12% and 9%, respectively, in 2016 alone, resulting in a large number of new hospital construction projects and thus soaring demand for medical and surgical equipment.

POCT devices contribute 7-8% in the medical device market. However, number of healthcare personnel stands at 7.2 million globally today, as the number of skilled healthcare workers decreases, there is a shift toward accurate, intuitive tests that can be operated by less skilled personnel and patients. POCT is one of the innovations that can potentially have impact on quality of care as well as on system redesign and a more patient centered approach to care.

Test volume wise US makes up majority of the market. Due to implementation CLIA and FDA standards, US is the most amenable to specialized POC. Although Europe is growing faster than US due to evolution of more and more physician office labs (POLs). Japan being highly centralized form of healthcare does not prefer POCT in POLs. However, POCT is preferred in emergency and critical care in Japan. The need of advance diagnosis is rising in developed nations as the awareness towards diagnostics is rising. Moreover, rising number of diagnostics labs in developing countries further expected to foster the demand for point of care devices in near future.

Market Drivers and Challenges:

Diabetes represents 67% of the market share and is the primary driver of POCT market followed by other highly growing segments include cardiac coagulations, infectious disease and blood gas with great optimization of care processes. MDx based tests for infectious diseases such as MRSA and Sepsis have significant growth potential as they are POC oriented.
Due to multiple testing platforms and manual POCT methods, possibility of complexity of data management and oversight rises. The Philippines and Taiwan are planning national guidelines for POCT. Investment costs for a single POCT assay systems may seem low but POCT devices are limited to one or few assays only and do not produce a fraction of results during their life cycle compared with instruments in the core laboratory.

Browse Full Report at:

Global Point Of Care Testing (POCT) Devices Market Report covered insights of below mentioned regions:

– North America (U.S., Canada) {Market Size, Growth Analysis and Opportunity Analysis}
-Latin America (Argentina, Mexico, Brazil and Rest of Latin America) {Market Size, Growth Analysis and Opportunity Analysis}
-Europe (Germany, Italy, Spain, France, The U.K., Netherlands, Sweden, Hungary, Russia, Poland, Rest of Europe) {Market Size, Growth Analysis and Opportunity Analysis}
-Asia-Pacific (China, India, Singapore, Japan, Hong-Kong, Australia, New Zealand, South Korea and Rest of Asia Pacific) {Market —Size, Growth Analysis and Opportunity Analysis}
-Middle East and North Africa (MENA) {Market Size, Growth Analysis and Opportunity Analysis}
-Rest of World {Market Size, Growth Analysis and Opportunity Analysis}

The report provides a basic overview of the Point Of Care Testing (POCT) Devices industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.

Then, the report focuses on Global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What’s more, the Point Of Care Testing (POCT) Devices industry development trends and marketing channels are analyzed.

The research includes historic data from 2013 to 2017 and forecasts until 2024 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs. The report will make detailed analysis mainly on above questions and in-depth research on the development environment, market size, development trend, operation situation and future development trend of Point Of Care Testing (POCT) Devices on the basis of stating current situation of the industry in 2018 so as to make comprehensive organization and judgment on the competition situation and development trend of Point Of Care Testing (POCT) Devices Market and assist manufacturers and investment organization to better grasp the development course of Point Of Care Testing (POCT) Devices Market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

About us:

MarketInsightsReports provides syndicated Market research reports to industries, organizations or even individuals with an aim of helping them in their decision making process. MarketInsightsReports has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

+1 (704) 266-3234 | mail to:

Connect with us on: